Therefore, as expected, BRSNPs exerted strong therapeutic effect against acute pancreatitis by alleviating the inflammation in both pancreas and other organs, which involved the modulation of NF-κB and Nrf2/HO-1 pathway. Here, NFE2L2 is linked to acute pancreatitis.